Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones

2025.12.03 22:19

I'm PortAI, I can summarize articles.

Bio-Techne Corp.'s stock rose 1.38% to $63.82 on Wednesday, ending a four-day losing streak. Despite gains, it underperformed compared to competitors like Amgen Inc., Charles River Laboratories, and BioMarin Pharmaceutical. The stock remains 19.50% below its 52-week high. The S&P 500 and Dow Jones also saw increases.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bio-Techne Corp. (TECH) rallied 1.38% to $63.82 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.30% to 6,849.72 and the Dow Jones Industrial Average rising 0.86% to 47,882.90. The stock's rise snapped a four-day losing streak. Bio-Techne Corp. closed 19.50% below its 52-week high of $79.28, which the company reached on February 5th. The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. (AMGN) rose 2.09% to $345.42, Charles River Laboratories International Inc. (CRL) rose 5.67% to $184.67, and BioMarin Pharmaceutical Inc. (BMRN) rose 0.78% to $54.31. Data source: Dow Jones Market Data, FactSet. Data compiled December 3, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-03-25 1719ET